Literature DB >> 21242786

Analysis of deposit depth and morphology in granular corneal dystrophy type 2 using fourier domain optical coherence tomography.

Jin Pyo Hong1, Tae-Im Kim, Jae Lim Chung, David Huang, Hyun Soo Cho, Eung Kweon Kim.   

Abstract

PURPOSE: Granular corneal dystrophy type 2 (GCD2) causes the formation of corneal deposits having 3 different morphological types. We used Fourier domain optical coherence tomography to assess the depths of each type according to the morphology.
METHODS: A prospective study was performed in 54 eyes of 54 heterozygous patients with GCD2. Corneal deposits of 54 patients with GCD2 were classified into 3 morphological types: type 1, diffuse haze; type 2, granular shape (2 subgroups: type 2a, round granulated and type 2b, round spiculated); and type 3, linear shape (2 subgroups: type 3a, short side branched and type 3b, long side branched). Using Fourier domain optical coherence tomography, we measured the distances from the Bowman layer to the upper surface of the deposits (USBL), to the lower surface of the deposits (LSBL), and the thickness of the deposits (TD). The deposits formed along the flap interface were also examined among 19 patients who had LASIK.
RESULTS: Types 1 and 2 deposits were always adjacent to the Bowman layer; thus the USBLs for each were 0.0 ± 0.0 μm, whereas that of type 3 deposits was 65.4 ± 48.0 μm (P < 0.0001). The LSBL and TD of linear deposits with long side branches (type 3) (313.3 ± 71.4 and 246.2 ± 71.9 μm) were greater than those of type 1 (47.7 ± 10.2 and 47.7 ± 10.2 μm) and type 2 (91.3 ± 39.5 and 91.3 ± 39.5 μm) (P < 0.0001). There were no differences in the measurements between the subgroups type 2a and type 2b or between types 3a and 3b. USBL of the laser in situ keratomileusis group was 54.5 ± 29.8 μm.
CONCLUSIONS: The depths of corneal deposits in patients with GCD2 were associated with the morphology of the deposits. The linear deposits were located most deeply in the cornea, followed by granular deposits and diffuse haze moving anteriorly. Several deposits have distinct depths according to the morphological types.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242786     DOI: 10.1097/ICO.0b013e3182000933

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

Review 1.  Characteristics of corneal dystrophies: a review from clinical, histological and genetic perspectives.

Authors:  Ze-Nan Lin; Jie Chen; Hong-Ping Cui
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

2.  Outcomes of photorefractive keratectomy instead of phototherapeutic keratectomy for patients with granular corneal dystrophy type 2.

Authors:  Fumika Oya; Takeshi Soma; Yoshinori Oie; Takeshi Nakao; Shizuka Koh; Motokazu Tsujikawa; Naoyuki Maeda; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-11       Impact factor: 3.117

3.  Role of optical coherence tomography on corneal surface laser ablation.

Authors:  Bruna V Ventura; Haroldo V Moraes; Newton Kara-Junior; Marcony R Santhiago
Journal:  J Ophthalmol       Date:  2012-09-05       Impact factor: 1.909

4.  Effect of Light Scattering and Higher-order Aberrations on Visual Performance in Eyes with Granular Corneal Dystrophy.

Authors:  Kazutaka Kamiya; Hidenaga Kobashi; Akihito Igarashi; Nobuyuki Shoji; Kimiya Shimizu
Journal:  Sci Rep       Date:  2016-04-18       Impact factor: 4.379

5.  Visual Outcomes Following Deep Anterior Lamellar Keratoplasty in Granular Corneal Dystrophy Types 1 and 2.

Authors:  Lia M Uit de Bosch; Susan Ormonde; Stuti L Misra
Journal:  Korean J Ophthalmol       Date:  2016-12-06

6.  Comparative Study of Anterior Eye Segment Measurements with Spectral Swept-Source and Time-Domain Optical Coherence Tomography in Eyes with Corneal Dystrophies.

Authors:  Anna K Nowinska; Sławomir J Teper; Dominika A Janiszewska; Anita Lyssek-Boron; Dariusz Dobrowolski; Robert Koprowski; Edward Wylegala
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.